Chemours (CC) Misses Q4 EPS by 12c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mail
Get Alerts CC Hot Sheet
Join SI Premium – FREE
Chemours (NYSE: CC) reported Q4 EPS of $0.81, $0.12 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.57 million.
GUIDANCE:
Chemours sees FY2022 EPS of $4.07-$4.70, versus the consensus of $4.54.
For earnings history and earnings-related data on Chemours (CC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Downgrades Chemours (CC) to Neutral
- Chemours falls as RBC downgrades stock on persistent TiO2 weakness
- Goldman Sachs (GS) Reiterated at Market Perform by Citizens as View of Earnings Opportunity Raised
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
